FireTofu
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Science · en

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

WIRED · Oct 24, 2026, 11:30 AM UTC

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.